On rare occasions, especially in older dogs, permanent hearing losses or deficits were reported. The use of these components has been associated with deafness or partial hearing loss in some dogs (e.g., geriatric).
#OTOMAX EAR SKIN#
The following have been reported occasionally in humans in connection with the use of clotrimazole: erythema, stinging, blistering, peeling, edema, pruritus, urticaria, and general irritation of the skin not present before therapy. Cushing’s syndrome in dogs has been reported in association with prolonged or repeated steroid therapy. Following the use of parenteral, high-dose and/or prolonged or systemic synthetic corticosteroids, such as betamethasone, in dogs, ALP (SAP) and ALT (SGPT) enzyme elevations, weight loss, anorexia, polydipsia, polyuria, neutrophilia and lymphopenia have occurred. All aminoglycosides have the potential to produce reversible and irreversible vestibular, cochlear, and renal toxicity. While aminoglycosides are absorbed poorly from skin, intoxication may occur when aminoglycosides are applied topically for prolonged periods of time to large wounds, burns, or any denuded skin, particularly if there is renal insufficiency. Do not handle the product if you have known hypersensitivity against compounds in the product. In case of accidental contact with the eyes, rinse with copious amounts of water. Wash hands carefully after applying the product.
Prolonged use or overdosage may produce adverse immunosuppressive effects. Patients should be closely observed for the usual signs of adrenocorticoid overdosage which include sodium retention, potassium loss, fluid retention, weight gain, polydipsia and/or polyuria. Experimentally, it has been demonstrated that corticosteroids, especially at high levels, may result in delayed wound healing.Īdverse systemic reactions have been observed following the oral ingestion of some topical corticosteroid preparations. If this occurs, treatment should be instituted with other appropriate agents as indicated. Use of topical antibiotic and antifungals may permit overgrowth of non-susceptible bacterial, fungi or yeast. Antibiotic susceptibility of the pathogenic organism(s) should be determined prior to use of this preparation. Do not use in dogs with known perforation of eardrums.ĬAUTIONS: Prior to treatment, it is recommended to conduct a clinical evaluation for evidence of hearing deficit and/or vestibular disorder. Concomitant use of drugs known to induce ototoxicity should be avoided. If hypersensitivity to any of the components occurs, treatment should be discontinued and appropriate alternate therapy instituted. Do not exceed the recommended period of treatment or frequency of application. Massage the external ear carefully after medication is instilled to assure proper distribution. Dogs weighing 15 kg or more: 8 drops for the 7.5 g, 12.5 g, 15 g and 30 g package sizes or 4 drops, for the 215 g package size, per affected ear. Dogs weighing less than 15 kg: 4 drops for the 7.5 g, 12.5 g, 15 g and 30 g package sizes or 2 drops, for the 215 g package size, per affected ear. Instill OTOMAX ointment into the cleaned external ear canal twice daily for 7 days.
Shake well before use when using the 12.5 g, 30 g and 215 g bottles. Excessive hair should be removed from the treatment area of the external ear.
Remove foreign material, debris, crusted exudates, etc., with suitable non-irritating solutions. The external ear and ear canal should be properly cleaned and dried before treatment. OTOMAX is indicated for the treatment of canine acute and chronic otitis externa associated with yeast ( Malassezia pachydermatis, formerly Pityrosporum canis) and/or bacteria susceptible to gentamicin. Gentamicin as sulfate is a water soluble (bactericidal) antibiotic of the aminoglycoside group, derived from Micromonospora, an actinomycete.īetamethasone valerate is a synthetic glucocorticoid derivative of prednisolone.Ĭlotrimazole is a synthetic antifungal belonging to the imidazole family.Įach gram of OTOMAX ointment contains 3 mg gentamicin as gentamicin sulfate USP, 1 mg betamethasone as betamethasone valerate USP, and 10 mg clotrimazole USP in a mineral oil based vehicle containing a plasticized hydrocarbon gel. Antibiotic, Anti-inflammatory, Antifungal